Hospital admission for asthma. a descriptive study and analysis of factors related to prognosis after relase;Ingreso en el hospital por asma. Análisis descriptive y factores pronósticos tras el alta

Archivos de Bronconeumologia

Volumn 35, Issue 8, 1999, Pages 372-378

  Serrano, J ^a   Plaza, V ^a   Sanchis, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Asthma; Descriptive study; Prognostic factors

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; ASTHMA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PROGNOSIS; REGRESSION ANALYSIS; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; SPAIN;

EID: 0032727937     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30053-3     Document Type: Article

References (34)

1. Evans R, Mullally DI, Wilson RW, Gergen PJ, Rosenberg HM, Grauman JS et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and dead form asthma over two decades: 1965-1984. Chest 1987; 91 (Supl): 65-74.
2. Asthma-United States, 1982-1992. MMWR 1995; 43: 952-955.
3. Wobig EK, Rosen P. Death from asthma: rare but real. J Emerg Med 1996; 14: 233-240.
4. Li D, German D, Lulla S, Thomas RG, Wilson SR. Prospective study of hospitalization for asthma. A preliminary risk factor model. Am J Respir Crit Care Med 1995; 151: 647-655.
5. Picado C, Benlloch E, Casan P, Duce F, Manresa F, Perpinyá M et al. Recomendaciones para el tratamiento del asma en los adultos. Arch Bronconeumol 1993; 29 (Supl): 8-13.
6. Grupo de trabajo de la SEPAR. Normativa sobre diagnóstico y tratamiento del asma aguda y crónica. Barcelona: Ediciones Doyma S.A., 1996.
7. Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y Sociedad Espanola de Medicina Familiar y Comunitaria (semFYC). Recomendaciones para la atención del paciente con asma. Arch Bronconeumol 1998; 34: 394-399.
8. International Consensus Report on Diagnosis and Treatment of Asthma. National Hearth, Lung and Blood Institute, National Institutes of Health. Bethesda, Maryland 20892. Publication n.o 92-3091. Eur Respir J 1992; 5: 601-641.
9. British Thoracic Society. The british guidelines on asthma management. 1995 review and position statement. Thorax 1997; 52 (Supl 1): 1-21.
10. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institute of Health. National Heart, Lung and Blood Institute. NIH Publication. Publication n.o 95-3659. January 1995.
11. Dales RE, Schweitzer I, Kerr P, Gougeon L, Rivington R, Draper J. Risk factors for recurrent emergency department visits for asthma. Thorax 1995; 520-524.
12. Coll I, Barreiro B, Canet JJ, Esteban LI, Heredia JL. Respuesta clínica al tratamiento de la crisis asmática en el Servicio de Urgencias. Arch Bronconeumol 1996; 32 (Supl 2): 43.
13. Pascal I, Galdiz JB; Gil P, Campo A, Uresandi F, Sobradillo V. Crisis asmática: características clínicas y funcionales durante la crisis y posterior seguimiento. Arch Bronconeumol 1996; 32 (Supl 2): 43.
14. Sanchis J, Casan P, Castillo J, Gonzalez N, Palenciano L, Roca J. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol 1989; 256: 132-142.
15. Valencia A, Casan P, Díaz M, Perpiñá M y Sebastián MD. Normativa de los tests de provocación bronquial inespecífica forzada. Arch Bronconeumol 1989; 25: 132-142.
16. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277: 887-891.
17. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992; 10: 301-310.
18. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1.405-1.411.
19. Prescott E, Lange P, Vestbo J y The Copenhagen City Heart Study Group. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Thorax 1997; 52: 287-289.
20. Skobeloff EM, Spivey WH, St. Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3.437-3.440.
21. Dales RE, Schweitzer I, Toogood JH, Drouin M, Yang W, Dolovich J et al. Respiratory infections and the autoumn increase in asthma morbidity. Eur Respir J 1996; 9: 72-77.
22. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996; 154: 654-660.
23. Priftis K, Anagnostakis J, Harokopos E, Orfanou I, Petraki M, Saxoni-Papageorgiou P. Time trends and seasonal variation in hospital admisions for childhood asthma in the Athens region of Greece: 1978-1988. Thorax 1993; 48: 1.168-1.169.
24. Osborne ML, Vollmer WM, Buist AS. Periodicity of asthma, emphysema, and chronic bronchitis in a northwest helath maintenance organization. Chest 1996; 110: 1.458-1.462.
25. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI, Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271: 1.412-1.416.
26. Greening AP, Ind PW, Northfield M, Shae G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing corticosteroid. Lancet 1994; 344: 219-224.
27. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1.481-1.488.
28. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Souhtern DL, Kemp JP et al. A comparison of salmeterol with albuterol in the treatment of mild-to-modrate asthma. N Engl J Med 1992; 327: 1.420-1.425.
29. Kesten S, Chapman KR; Broder I, Cartier A, Hyland RH, Knight A et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622-625.
30. Rogado MC, De Diego A, De la Cuadra P, Perpiñá M, Compte L, Leon M. Crisis asmática en los Servicios de Urgencias. ¿Se cumplen las normativas? Arch Bronconeumol 1996; 32 (Supl 2): 37.
31. Schilling RJ, Hurding SB, Maddocks JL. Care of asthmatics on discharge from hospital: a hospital audit. J Asthma 1995; 32: 161-163.
32. Hartert TV, Windom HH, Peebles RS, Freidhoff LR, Togias A. Inadequate outpatient medical therapy for patients with asthma admitted to two urban hospitals. Am J Med 1996; 100: 386-394.
33. McLeod SJ, Pearce MJ, Rigby SA, Beeg EJ, Beard MEJ, Martin IR et al. ASthma management at Christchurch Hospital: compliance with guidelines. N Z Med J 1996; 109: 115-118.
34. Mitchell EA, Bland JM, Thompson JMD. Risk factors for readmission to hospital for asthma in childhood. Thorax 1994; 49: 33-36.